Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
enoxaparin (lovenox) (1 trial)
alpha-1 antitrypsin (Prolastin) (1 trial)
alpha 1-Antitrypsin Deficiency (Phase 1)
Embolism (Phase 4)
Pulmonary Embolism (Phase 4)
Thrombosis (Phase 4)
Venous Thrombosis (Phase 4)
Trials (2 total)
Trial APIs (2 total)